Common blood pressure drug could make cancer therapy far more powerful

ScienceDaily reports that a commonly prescribed blood pressure medication called telmisartan may significantly enhance the effectiveness of the cancer drug olaparib. In preclinical studies, researchers found that combining the two showed strong immune-boosting and anticancer effects, and the combination is now being tested in human trials. The finding could be significant because it potentially expands olaparib's benefits beyond patients with BRCA-related tumors to a much wider patient population.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton